Renata Varga

Renata Varga is principal scientist, Teva Branded Pharmaceutical Products R&D, Inc.


Overcoming Challenges to Biopharmaceutical Development and Manufacture with Science- and Risk-Based Strategies

Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.